Skip to main content
Erschienen in: Infection 6/2021

08.08.2021 | Original Paper

Evaluation of a point-of-care molecular detection device for Leishmania spp. and intercurrent fungal and mycobacterial organisms in Peruvian patients with cutaneous ulcers

verfasst von: Ruwandi Kariyawasam, Braulio M. Valencia, Rachel Lau, Eric Shao, Courtney A. Thompson, Michael Stevens, Leah Kincaid, Ana Luz Quispe Del Castillo, Lloysi O. Cruz-Arzapalo, Alejandro Llanos-Cuentas, Andrea K. Boggild

Erschienen in: Infection | Ausgabe 6/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Overlapping clinical features of cutaneous leishmaniasis (CL) with ulcers caused by fungi and mycobacteria necessitate confirmatory diagnostic testing. We evaluated a handheld battery-operated device for detection of CL and common fungal and mycobacterial causes of ulcers.

Methods

We validated Palm PCR™ for detection of common ulcerative skin pathogens using ATCC® reference and clinical strains of Leishmania, mycobacteria, and fungi in the lab and field. Amplified products were Sanger sequenced. Performance characteristics were calculated using conventional PCR as a reference standard.

Results

Palm PCR™ detected 100% of ATCC® strains of Leishmania, fungi, and mycobacteria, with sensitivity and specificity of 90% and 91.7%, respectively. In the field, the sensitivity for detection of Leishmania in patients with suspected CL was 100%. In 61% of CL patients, co-colonization with genera such as Malassezia, Aspergillus, Candida, and Cladosporium was detected. In 50% of CL patients with an inflammatory (secondarily infected) phenotype, detected fungal species had known associations with human cutaneous disease.

Conclusions

Palm PCR™ performs comparably to conventional PCR for detection of Leishmania, fungi, and mycobacteria. This work has implications for the diagnostic approach to tropical ulcers, and has the potential to improve field detection of ulcerative pathogens in resource constrained areas.
Literatur
1.
Zurück zum Zitat Reithinger R, Dujardin JC, Louzir H, Pirmez C, Alexander B, Brooker S. Cutaneous leishmaniasis. Lancet Infect Dis. 2007;7:581–96.CrossRef Reithinger R, Dujardin JC, Louzir H, Pirmez C, Alexander B, Brooker S. Cutaneous leishmaniasis. Lancet Infect Dis. 2007;7:581–96.CrossRef
2.
Zurück zum Zitat World Health Organization. Control of the leishmaniasis. World Health Organ Tech Rep Ser. 2010;949:22–6. World Health Organization. Control of the leishmaniasis. World Health Organ Tech Rep Ser. 2010;949:22–6.
3.
Zurück zum Zitat Torres-Guerrero E, Quintanilla-Cedillo MR, Ruiz-Esmenjaud J, Arenas R. Leishmaniasis: a review. F1000Res. 2017;6:750.CrossRef Torres-Guerrero E, Quintanilla-Cedillo MR, Ruiz-Esmenjaud J, Arenas R. Leishmaniasis: a review. F1000Res. 2017;6:750.CrossRef
4.
Zurück zum Zitat Aronson N, Herwaldt BL, Libman M, et al. Diagnosis and guidelines treatment of leishmaniasis: clinical practice by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Clin Infect Dis. 2016;63:e202–64.CrossRef Aronson N, Herwaldt BL, Libman M, et al. Diagnosis and guidelines treatment of leishmaniasis: clinical practice by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Clin Infect Dis. 2016;63:e202–64.CrossRef
5.
Zurück zum Zitat Rodriguez-Brito S, Camacho E, Mendoza M, Nino-Vega GA. Differential identification of Sporothrix spp. and Leishmania spp. by conventional PCR and qPCR in multiplex format. Med Mycol. 2005;53:22–7.CrossRef Rodriguez-Brito S, Camacho E, Mendoza M, Nino-Vega GA. Differential identification of Sporothrix spp. and Leishmania spp. by conventional PCR and qPCR in multiplex format. Med Mycol. 2005;53:22–7.CrossRef
6.
Zurück zum Zitat Vincente CR, Falgueto A. Differentiation of mucosal lesions in mucocutaneous leishmaniasis and paracoccidioidomycosis. PLoS ONE. 2018;13: e0208208.CrossRef Vincente CR, Falgueto A. Differentiation of mucosal lesions in mucocutaneous leishmaniasis and paracoccidioidomycosis. PLoS ONE. 2018;13: e0208208.CrossRef
7.
Zurück zum Zitat Martinez DY, Verdonck K, Kaye PM, et al. Tegumentary leishmaniasis and coinfections other than HIV. PLoS NTDs. 2018;12: e0006125. Martinez DY, Verdonck K, Kaye PM, et al. Tegumentary leishmaniasis and coinfections other than HIV. PLoS NTDs. 2018;12: e0006125.
8.
Zurück zum Zitat Martinez E, Torres-Guerrero E, Cortes E, Tejanda D, Arenas R. Cryptococcus laurentii infection in a patient with cutaneous leishmaniasis. Int J Dermatol. 2017;56:e56–7.CrossRef Martinez E, Torres-Guerrero E, Cortes E, Tejanda D, Arenas R. Cryptococcus laurentii infection in a patient with cutaneous leishmaniasis. Int J Dermatol. 2017;56:e56–7.CrossRef
9.
Zurück zum Zitat de Lima Barros MB, Schubach A, Francesconi-do-Valle AC, et al. Positive Montenegro skin test among patients with sporotrichosis in Rio de Janeiro. Acta Trop. 2005;93:41–7.CrossRef de Lima Barros MB, Schubach A, Francesconi-do-Valle AC, et al. Positive Montenegro skin test among patients with sporotrichosis in Rio de Janeiro. Acta Trop. 2005;93:41–7.CrossRef
10.
Zurück zum Zitat Garcia Bustos MF, Gonzalez-Prieto G, Ramos F, et al. Clinical and epidemiological features of leishmaniasis in northwestern-Argentina through a retrospective analysis of recent cases. Acta Trop. 2016;154:125–32.CrossRef Garcia Bustos MF, Gonzalez-Prieto G, Ramos F, et al. Clinical and epidemiological features of leishmaniasis in northwestern-Argentina through a retrospective analysis of recent cases. Acta Trop. 2016;154:125–32.CrossRef
11.
Zurück zum Zitat Delobal P, Launois P, Djossou F, Sainte-Marie D, Pradinaud R. American cutaneous leishmaniasis, lepromatous leprosy and pulmonary tuberculosis coinfection with downregulation of the T-helper 1 cell response. Clin Infect Dis. 2003;37:628–33.CrossRef Delobal P, Launois P, Djossou F, Sainte-Marie D, Pradinaud R. American cutaneous leishmaniasis, lepromatous leprosy and pulmonary tuberculosis coinfection with downregulation of the T-helper 1 cell response. Clin Infect Dis. 2003;37:628–33.CrossRef
12.
Zurück zum Zitat Escobar MA, Saravia NG, Weigle KA. Concurrent mucosal leishmaniasis and pulmonary tuberculosis. Clin Infect Dis. 1996;23:836–7.CrossRef Escobar MA, Saravia NG, Weigle KA. Concurrent mucosal leishmaniasis and pulmonary tuberculosis. Clin Infect Dis. 1996;23:836–7.CrossRef
13.
Zurück zum Zitat Azeredo-Coutinho RB, Matos DC, Nery JA, Valente-Rosalino CM, Mendonca SC. Interleukin-10-dependent down-regulation of interferon-gamma response to Leishmania by Mycobacterium leprae antigens during the clinical course of a coinfection. Braz J Med Biol Res. 2012;45:632–6.CrossRef Azeredo-Coutinho RB, Matos DC, Nery JA, Valente-Rosalino CM, Mendonca SC. Interleukin-10-dependent down-regulation of interferon-gamma response to Leishmania by Mycobacterium leprae antigens during the clinical course of a coinfection. Braz J Med Biol Res. 2012;45:632–6.CrossRef
14.
Zurück zum Zitat Mortazavi H, Soori T, Khamesipour A, Khatami A, Vasheghani-Farahani A. Co-existence of cutaneous leishmaniasis with pleural effusion: a case report from Iran. Acta Med Iran. 2014;52:231–3.PubMed Mortazavi H, Soori T, Khamesipour A, Khatami A, Vasheghani-Farahani A. Co-existence of cutaneous leishmaniasis with pleural effusion: a case report from Iran. Acta Med Iran. 2014;52:231–3.PubMed
15.
Zurück zum Zitat Patrao NA, Bhat RM, Dandekeri S, Kambil SM. Diffuse cutaneous leishmaniasis in coexistence with leprosy. Int J Dermatol. 2015;54:1402–6.CrossRef Patrao NA, Bhat RM, Dandekeri S, Kambil SM. Diffuse cutaneous leishmaniasis in coexistence with leprosy. Int J Dermatol. 2015;54:1402–6.CrossRef
16.
Zurück zum Zitat Torrealba J, Mendoza I, Ocanta T, Barroeta S, Mejia de Alejos MA, Bonfante-Garrido R. Concomitant cutaneous leishmaniasis and leprosy in Venezuela. Trans R Soc Trop Med Hyg. 1995;89:69.CrossRef Torrealba J, Mendoza I, Ocanta T, Barroeta S, Mejia de Alejos MA, Bonfante-Garrido R. Concomitant cutaneous leishmaniasis and leprosy in Venezuela. Trans R Soc Trop Med Hyg. 1995;89:69.CrossRef
17.
Zurück zum Zitat Even-Paz Z, Haas H, Sacks T, Rosenmann E. Mycobacterium marinum skin infections mimicking cutaneous leishmaniasis. Br J Dermatol. 1976;94:435–42.CrossRef Even-Paz Z, Haas H, Sacks T, Rosenmann E. Mycobacterium marinum skin infections mimicking cutaneous leishmaniasis. Br J Dermatol. 1976;94:435–42.CrossRef
18.
Zurück zum Zitat Dassoni F, Abebe Z, Naafs B, Morrone A. Cutaneous and mucocutaneous leishmaniasis resembling borderline-tuberculoid leprosy: a new clinical presentation? Acta Derm Venereol. 2013;93:74–7.CrossRef Dassoni F, Abebe Z, Naafs B, Morrone A. Cutaneous and mucocutaneous leishmaniasis resembling borderline-tuberculoid leprosy: a new clinical presentation? Acta Derm Venereol. 2013;93:74–7.CrossRef
19.
Zurück zum Zitat Pavlidakey PG, Huynh T, McKay KM, Sami N. Leishmaniasis panamensis masquerading as myiasis and sporotrichosis: a clinical pitfall. Case Rep Pathol. 2015;2015:949670.PubMedPubMedCentral Pavlidakey PG, Huynh T, McKay KM, Sami N. Leishmaniasis panamensis masquerading as myiasis and sporotrichosis: a clinical pitfall. Case Rep Pathol. 2015;2015:949670.PubMedPubMedCentral
20.
Zurück zum Zitat Peçanha PM, Ferreira MEB, Peçanha MAM, et al. Paracoccidioidomycosis: epidemiological and clinical aspects in 546 cases studied in the state of Espírito Santo, Brazil. Am J Trop Med Hyg. 2017;97:836–44.CrossRef Peçanha PM, Ferreira MEB, Peçanha MAM, et al. Paracoccidioidomycosis: epidemiological and clinical aspects in 546 cases studied in the state of Espírito Santo, Brazil. Am J Trop Med Hyg. 2017;97:836–44.CrossRef
21.
Zurück zum Zitat Agudelo SP, Restrepo S, Vélez ID. Cutaneous new world leishmaniasis-sporotrichosis coinfection: report of 3 cases. J Am Acad Dermatol. 1999;40:1002–4.CrossRef Agudelo SP, Restrepo S, Vélez ID. Cutaneous new world leishmaniasis-sporotrichosis coinfection: report of 3 cases. J Am Acad Dermatol. 1999;40:1002–4.CrossRef
22.
Zurück zum Zitat Alvar J, Yactayo S, Bern C. Leishmaniasis and poverty. Trends Parasitol. 2006;22:552–7.CrossRef Alvar J, Yactayo S, Bern C. Leishmaniasis and poverty. Trends Parasitol. 2006;22:552–7.CrossRef
23.
Zurück zum Zitat Desjeux P. Leishmaniasis: public health aspects and control. Clin Dermatol. 1996;14:417–23.CrossRef Desjeux P. Leishmaniasis: public health aspects and control. Clin Dermatol. 1996;14:417–23.CrossRef
24.
Zurück zum Zitat Reithinger R, Dujardin J-C. Molecular diagnosis of leishmaniasis: current status and future applications. J Clin Microbiol. 2007;45:21–5.CrossRef Reithinger R, Dujardin J-C. Molecular diagnosis of leishmaniasis: current status and future applications. J Clin Microbiol. 2007;45:21–5.CrossRef
25.
Zurück zum Zitat Pineda-Reyes R, Llanos-Cuentas A, Dancuart M. [Traditional treatments in an endemic area of American cutaneous leishmaniasis in Peru]. Rev Peru Med Exp Salud Publica. 2015;32:761–5.CrossRef Pineda-Reyes R, Llanos-Cuentas A, Dancuart M. [Traditional treatments in an endemic area of American cutaneous leishmaniasis in Peru]. Rev Peru Med Exp Salud Publica. 2015;32:761–5.CrossRef
26.
Zurück zum Zitat den Boer M, Argaw D, Jannin J, Alvar J. Leishmaniasis impact and treatment access. Clin Microbiol Infect. 2011;17:1471–7.CrossRef den Boer M, Argaw D, Jannin J, Alvar J. Leishmaniasis impact and treatment access. Clin Microbiol Infect. 2011;17:1471–7.CrossRef
27.
Zurück zum Zitat Hodiamont CJ, Kager PA, Bart A, et al. Species-directed therapy for leishmaniasis in returning travellers: a comprehensive guide. PLoS Negl Trop Dis. 2014;8: e2832.CrossRef Hodiamont CJ, Kager PA, Bart A, et al. Species-directed therapy for leishmaniasis in returning travellers: a comprehensive guide. PLoS Negl Trop Dis. 2014;8: e2832.CrossRef
28.
Zurück zum Zitat Showler AJ, Boggild AK. Cutaneous leishmaniasis in travellers: a focus on epidemiology and treatment in 2015. Curr Infect Dis Rep. 2015;17:37.CrossRef Showler AJ, Boggild AK. Cutaneous leishmaniasis in travellers: a focus on epidemiology and treatment in 2015. Curr Infect Dis Rep. 2015;17:37.CrossRef
29.
Zurück zum Zitat Schallig HDFH, Hu RVP, Kent AD, van Loenen M, Menting S, Picado A, Oosterling Z, Cruz I. Evaluation of point of care tests for the diagnosis of cutaneous leishmaniasis in Suriname. BMC Infect Dis. 2019;19:25.CrossRef Schallig HDFH, Hu RVP, Kent AD, van Loenen M, Menting S, Picado A, Oosterling Z, Cruz I. Evaluation of point of care tests for the diagnosis of cutaneous leishmaniasis in Suriname. BMC Infect Dis. 2019;19:25.CrossRef
30.
Zurück zum Zitat Vink MMT, Nahzat SM, Rahimi H, et al. Evaluation of point-of-care tests for cutaneous leishmaniasis in Kabul, Afghanistan. EBioMedicine. 2018;37:453–60.CrossRef Vink MMT, Nahzat SM, Rahimi H, et al. Evaluation of point-of-care tests for cutaneous leishmaniasis in Kabul, Afghanistan. EBioMedicine. 2018;37:453–60.CrossRef
31.
Zurück zum Zitat Kato H, Caceres AG, Mimori T, et al. Use of FTA cards for direct sampling of patients’ lesions in the ecological study of cutaneous leishmaniasis. J Clin Microbiol. 2010;48:3661–5.CrossRef Kato H, Caceres AG, Mimori T, et al. Use of FTA cards for direct sampling of patients’ lesions in the ecological study of cutaneous leishmaniasis. J Clin Microbiol. 2010;48:3661–5.CrossRef
32.
Zurück zum Zitat Caliendo AM, Gilbert DN, Ginocchio CC, et al. Better tests, better care: improved diagnostics for infectious diseases. Clin Infect Dis. 2013;57:S139–70.CrossRef Caliendo AM, Gilbert DN, Ginocchio CC, et al. Better tests, better care: improved diagnostics for infectious diseases. Clin Infect Dis. 2013;57:S139–70.CrossRef
34.
Zurück zum Zitat Mary C, Faraut F, Lascombe L, Dumon H. Quantification of Leishmania infantum DNA by a real-time PCR assay with high sensitivity. J Clin Microbiol. 2004;42:5249–55.CrossRef Mary C, Faraut F, Lascombe L, Dumon H. Quantification of Leishmania infantum DNA by a real-time PCR assay with high sensitivity. J Clin Microbiol. 2004;42:5249–55.CrossRef
35.
Zurück zum Zitat Phuong M, Lau R, Ralevski F, Boggild AK. Survival analysis of diagnostic assays in Plasmodium falciparum malaria. Malar J. 2015;14:350.CrossRef Phuong M, Lau R, Ralevski F, Boggild AK. Survival analysis of diagnostic assays in Plasmodium falciparum malaria. Malar J. 2015;14:350.CrossRef
36.
Zurück zum Zitat Shokoples SE, Ndao M, Kowalewska-Grochowska K, Yanow SK. Multiplexed real-time PCR assay for discrimination of Plasmodium species with improved sensitivity for mixed infections. J Clin Microbiol. 2009;47:975–80.CrossRef Shokoples SE, Ndao M, Kowalewska-Grochowska K, Yanow SK. Multiplexed real-time PCR assay for discrimination of Plasmodium species with improved sensitivity for mixed infections. J Clin Microbiol. 2009;47:975–80.CrossRef
37.
Zurück zum Zitat Zelanzy AM, Root JM, Shea YR, et al. Cohort study of molecular identification and typing of Mycobacterium abscessus, Mycobacterium massiliense and Mycobacterium bolletii. J Clin Microbiol. 2009;47:1985–95.CrossRef Zelanzy AM, Root JM, Shea YR, et al. Cohort study of molecular identification and typing of Mycobacterium abscessus, Mycobacterium massiliense and Mycobacterium bolletii. J Clin Microbiol. 2009;47:1985–95.CrossRef
39.
Zurück zum Zitat Kosack CS, Page AL, Klaster PR. A guide to aid the selection of diagnostic tests. Bull World Health Org. 2017;95:639–45.CrossRef Kosack CS, Page AL, Klaster PR. A guide to aid the selection of diagnostic tests. Bull World Health Org. 2017;95:639–45.CrossRef
40.
Zurück zum Zitat Drain PK, Hyle EP, Noubary F, et al. Evaluating diagnostic point-of-care tests in resource-limited settings. Lancet Infect Dis. 2015;14:239–49.CrossRef Drain PK, Hyle EP, Noubary F, et al. Evaluating diagnostic point-of-care tests in resource-limited settings. Lancet Infect Dis. 2015;14:239–49.CrossRef
41.
Zurück zum Zitat Solomon M, Sahar N, Pavlotzky F, Barzilai A, Jaffe CL, Nasereddin A, Schwartz E. Mucosal leishmaniasis in travelers with Leishmania braziliensis complex returning to Israel. Emerg Infect Dis. 2019;25:642–8.CrossRef Solomon M, Sahar N, Pavlotzky F, Barzilai A, Jaffe CL, Nasereddin A, Schwartz E. Mucosal leishmaniasis in travelers with Leishmania braziliensis complex returning to Israel. Emerg Infect Dis. 2019;25:642–8.CrossRef
Metadaten
Titel
Evaluation of a point-of-care molecular detection device for Leishmania spp. and intercurrent fungal and mycobacterial organisms in Peruvian patients with cutaneous ulcers
verfasst von
Ruwandi Kariyawasam
Braulio M. Valencia
Rachel Lau
Eric Shao
Courtney A. Thompson
Michael Stevens
Leah Kincaid
Ana Luz Quispe Del Castillo
Lloysi O. Cruz-Arzapalo
Alejandro Llanos-Cuentas
Andrea K. Boggild
Publikationsdatum
08.08.2021
Verlag
Springer Berlin Heidelberg
Erschienen in
Infection / Ausgabe 6/2021
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-021-01673-y

Weitere Artikel der Ausgabe 6/2021

Infection 6/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.